Results 1 to 10 of about 7,176,843 (353)

Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19

open access: yesJournal of Patient-Reported Outcomes, 2022
Background Given the urgent need for vaccines and treatments for coronavirus disease 2019 (COVID-19), the Symptoms of Infection with Coronavirus-19 (SIC), a comprehensive, patient-reported outcome (PRO) measure of signs and symptoms associated with COVID-
Carla Romano   +11 more
doaj   +1 more source

Correlated physical and mental health composite scores for the RAND-36 and RAND-12 health surveys: can we keep them simple?

open access: yesHealth and Quality of Life Outcomes, 2022
Background The RAND-36 and RAND-12 (equivalent to versions 1 of the SF-36 Health Survey and SF-12 Health Survey, respectively) are widely used measures of health-related quality of life.
John Roger Andersen   +7 more
doaj   +1 more source

Patient-Reported Outcomes

open access: yesJACC: Heart Failure, 2019
Authors of systematic reviews that include patient-reported outcomes (PROs) should have a good understanding of how patient-reported outcome measures (PROMs) are developed, including the constructs they are intended to measure, their reliability, validity and responsiveness.
Johnston, Bradley C.   +21 more
  +11 more sources

Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study

open access: yesBMC Cancer, 2022
Background Ovarian cancer patients require monitoring for relapse. Innovative follow-up methods are increasingly being explored. An electronic patient-reported outcome (ePRO) follow-up pathway was developed for women treated for ovarian cancer.
Fiona Kennedy   +6 more
doaj   +1 more source

Symptom burden and health-related quality of life impacts of smoldering multiple myeloma: the patient perspective

open access: yesJournal of Patient-Reported Outcomes, 2020
Background Smoldering multiple myeloma (SMM) is an early form of multiple myeloma (MM). SMM is typically considered asymptomatic, and research on how it affects health-related quality of life (HRQoL) is limited. This study assessed the symptoms and HRQoL
Milenka Jean-Baptiste   +3 more
doaj   +1 more source

Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

open access: yesTrials, 2022
Background Tissue-agnostic drug development provides a paradigm shift in precision medicine and requires innovative trial designs. However, outcome selection for such trials can prove challenging.
Olalekan Lee Aiyegbusi   +5 more
doaj   +1 more source

Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study

open access: yesHealth and Quality of Life Outcomes, 2020
Background Rare diseases may be life-threatening or chronically debilitating conditions. Patient care needs are often complex and challenging to coordinate and deliver effectively.
Olalekan Lee Aiyegbusi   +7 more
doaj   +1 more source

Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection

open access: yesNature Communications, 2022
The collection of patient-reported outcomes (PROs) may capture patients’ assessments of their health status. Here authors highlight PRO-specific issues that should be considered to minimise respondent burden in clinical trials and routine care.
Olalekan Lee Aiyegbusi   +7 more
doaj   +1 more source

‘Give Us The Tools!’: development of knowledge transfer tools to support the involvement of patient partners in the development of clinical trial protocols with patient-reported outcomes (PROs), in accordance with SPIRIT-PRO Extension

open access: yesBMJ Open, 2021
Objectives (a) To adapt the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-patient-reported outcome (PRO) Extension guidance to a user-friendly format for patient partners and (b) to codesign a web-based tool to support the ...
Ameeta Retzer   +13 more
doaj   +1 more source

Co-production of a feasibility trial of pacing interventions for Long COVID

open access: yesResearch Involvement and Engagement, 2023
Plain English summary The World Health Organisation defines Long COVID as a condition which impacts people 3 months after they first had COVID-19. Some of the symptoms that characterise Long COVID symptoms include fatigue, breathlessness and brain fog ...
Grace M. Turner   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy